Skip to content

Clinical trials

Uterine Cervical Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Clear all

2,239 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200019
200121
200224
200338
200435
200539
200655
200757
200852
200964
201059
201158
201268
201351
201460
201585
201663
201792
201897
2019117
2020131
2021144
2022136
2023158
2024179
2025157
2026116

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed945
Unknown status420
Recruiting365
Terminated151
Active, not recruiting141
Not yet recruiting133
Withdrawn58
Enrolling by invitation18
Suspended7
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)69
M.D. Anderson Cancer Center54
Gynecologic Oncology Group45
GlaxoSmithKline31
Merck Sharp & Dohme LLC29
Peking Union Medical College Hospital28
Tata Memorial Hospital26
Lei Li22
UNC Lineberger Comprehensive Cancer Center21
Sun Yat-sen University18

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms2,239
Endometrial Neoplasms326
Ovarian Neoplasms318
Breast Neoplasms219
Uterine Cervical Dysplasia175
Papillomavirus Infections166
Vulvar Neoplasms155
Carcinoma, Non-Small-Cell Lung153
Neoplasms147
Vaginal Neoplasms139

Trials

Showing 26 to 50 of 2,239. Each trial links to its page on Pharma Observatory.

2,139 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.